Featured
APC sells governorship nomination form at N22.5m for Ekiti, Osun elections
The All Progressives Congress (APC) sells the party governorship nomination forms a N22.5 million for the isolated elections in Ekiti and Osun states, respectively. The National Secretary of APC Caretaker/Extraordinary Convention Planning Committee (CECPC), John Akpanudode, in the timetable and schedule of activities for the elections released on Monday, indicated that the N22.5 million is for the nomination and expression of interest forms for aspirants for the respective APC governorship ticket for the elections in Ekiti and Osun states.
The breakdown of the cost indicated N20 million is the cost of the APC nomination form, while N2.5 million is for the expression of interest form.
The APC reduced the cost of the forms by 50% for female and physically challenged aspirants. The party declared: “However, female aspirants and physically challenged aspirants are to pay 50% of the prescribed fees.”
The Independent National Electoral Commission (INEC) had scheduled Ekiti State governorship election to hold on June 18, while the Osun election is scheduled for July 16, 2022.
The payment of the N22.5 million for the governorship nomination form is not a guarantee of getting the ticket. The APC was, however, silent on what happens to the N22.5 million after an aspirant does not get the ticket.
-
Football1 week agoXabi Alonso targets Arda Guler as Chelsea prepare €100m transfer bid
-
Football1 week agoFIFA confirms Jay-Jay Okocha holds World Cup record
-
Business7 days agoDangote cuts petrol, diesel prices again to boost affordability, economic activity
-
Aviation1 week agoInside Airport Luggage Theft: Experts warn of rising insider syndicates
-
Politics1 week agoAmuwo Odofin: Umeadi emerges winner of NDC Reps Primary
-
Featured1 week agoPSG edge Arsenal on penalties to retain Champions League crown
-
Football1 week agoChampions League Final: Talking points ahead of Arsenal vs. PSG match
-
Health4 days agoSenate hearing set to review research on COVID-19 vaccines, cancer concerns

